Marian L Plunkett

Author PubWeight™ 5.33^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo.	Mol Cancer Ther	2006	1.29
2	Angiogenesis blockade as a new therapeutic approach to experimental colitis.	Gut	2006	1.26
3	Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain.	Cancer Res	2002	1.14
4	Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growth.	Clin Cancer Res	2008	0.93
5	Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities.	Cancer Res	2004	0.85